| Paul Slater
Health & Pharmaceuticals
AAI filed an amicus brief urging the Supreme Court to grant certiorari to reverse the Second Circuit’s rule of virtual per se legality for payments by branded drug manufacturers to delay entry by generics. The brief was written by attorney Paul Slater.